GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

59.10 -4.28 (-6.75%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2026 Add to My Watchlist

Price and Volume

Volume	429,445
Open	63.65
Bid (Size)	56.99 (100)
Ask (Size)	63.00 (100)
Prev. Close	63.38
Today's Range	58.96 - 64.91
52wk Range	32.21 - 170.87
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Today 17:21 EDT

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 24, 2026) - Kahn Swick & Foti, LLC ("KSF")...

Via Newsfile

WGS Deadline: Rosen Law Firm Urges GeneDx Holdings Corp. (NASDAQ: WGS) Stockholders to Contact the Firm for Information About Their Rights

July 23, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

Performance

YTD	-55.3%	-55.3%
1 Month	+1.8%	+1.8%
3 Month	-10.8%	-10.8%
6 Month	-42.0%	-42.0%
1 Year	-28.8%	-28.8%

More News

GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS

July 23, 2026

From SkyMedia, LLC

Via GlobeNewswire

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm

July 23, 2026

From Schall Law

Via GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 22, 2026

Via Newsfile

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 21, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

INVESTOR DEADLINE ALERT: GeneDx Holdings Corp. (WGS) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

July 21, 2026

Via NewMediaWire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines – WGS

July 21, 2026

From Pomerantz LLP

Via GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 20, 2026

Via Newsfile

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm

July 20, 2026

From Schall Law

Via GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 17, 2026

Via Newsfile

GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026

July 16, 2026

From GeneDx

Via Business Wire

GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS

July 16, 2026

From SkyMedia, LLC

Via GlobeNewswire

GeneDx Holdings Corp. Class Action Reminder – Robbins LLP Encourages WGS Investors to Contact the Firm for Information About Their Rights

July 16, 2026

From Robbins LLP

Via Business Wire

GENEDX HOLDINGS CORP. (WGS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds GeneDx Holdings Corp. Investors of Upcoming Deadline

July 16, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 14, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines – WGS

July 14, 2026

From Pomerantz LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the Firm

July 13, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

WGS ALERT: GeneDx Holdings Corp. Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit

July 12, 2026

Via NewMediaWire

Robbins LLP Urges WGS Stockholders to Contact the Firm for Information About Leading the Shareholder Class Action Against GeneDx Holdings Corp.

July 09, 2026

Via Newsfile

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 09, 2026

From SkyMedia, LLC

Via GlobeNewswire

WGS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GeneDx Holdings Corp. Securities Lawsuit - Contact Levi & Korsinsky

July 09, 2026

From Levi & Korsinsky, LLP

Via Business Wire

WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm

July 09, 2026

From Schall Law

Via GlobeNewswire

GENEDX HOLDINGS CORP. (WGS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds GeneDx Holdings Corp. Investors of Upcoming Deadline

July 09, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 08, 2026

Via Newsfile

Frequently Asked Questions

Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?

Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.

What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?

GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?

The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market

What is the current price of GeneDx Holdings Corp. - Class A Common Stock?

The current price of GeneDx Holdings Corp. - Class A Common Stock is 59.10

When was GeneDx Holdings Corp. - Class A Common Stock last traded?

The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 07/24/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.